Reimbursement and market access
FDA clearance tells the market your product is safe and effective. Reimbursement decides whether anyone can afford to use it. Shorelight Medical helps you build the coding, payment and value story that gets payers, providers and health systems to say yes, ideally planned alongside your regulatory strategy, not after launch.
Who It's For
- Medtech and life science companies of any kind (devices, diagnostics, drugs, digital health and software) whose product depends on insurer or health-system payment
- Companies introducing new care models, such as remote monitoring, chronic care and adherence programs, that need a clear path to payment
What's included
- Reimbursement strategy: how your product will be paid for, and by whom
- Coding and payment pathway analysis: which existing codes, coverage and payment apply, and where the gaps are
- Payer access planning: a plan for commercial payers and government programs such as Medicare and Medicaid
- Health economics support: the cost and outcomes evidence payers and health systems ask for
- Market access strategy: aligning pricing, reimbursement and channel so buyers can say yes
- Adoption and value positioning: the value story for providers, health systems and payers
How it works
Free 1-hour discovery call
We learn about your product, who will pay for it, and where you are in development. No cost and no obligation.
Proposal
If there’s a fit, we send a written proposal with scope, timeline and fees. Paid work, including any further discovery sessions, begins only after you approve it.
Assessment
We map the current coding, coverage and payment landscape for your product.
Strategy
We build a reimbursement and access plan that lines up with your regulatory and launch plans.
Execution Support
Value materials, payer engagement planning and adoption support.
Why Shorelight
We plan reimbursement alongside regulatory strategy and launch, so your product reaches market with a path to payment, not just a clearance.
- More than 30 years of combined experience in medtech and life science commercialization, spanning sales, product development, marketing strategy and market launch.
- Founder-led. Founder and CEO Stephen Brown brings 17 years of sales experience, 13 of them in medical device sales, along with experience in product development and new product launches.
- Marketing and commercialization expertise. Our team brings marketing strategy and execution plus hands-on commercialization experience, so your product launches with a clear message and a plan to reach buyers.
- One team, trusted partners. A vetted network of partners across every service (product development, regulatory and quality, reimbursement and market access, sales and marketing, and manufacturing and supply chain), all coordinated by Shorelight.
FAQ
When should we start planning for reimbursement?
As early as possible, ideally before your regulatory submission. Decisions about intended use and clinical evidence affect coding, coverage and payment later.
Do you work with digital health and remote monitoring companies?
Digital health, remote monitoring, chronic care, diagnostics and adherence technologies are a particular focus.
What if there's no existing code for my product?
We assess your options, which may include existing codes, pursuing new ones, or alternative payment and contracting models, and build a pathway that fits your launch plan.
Not sure how your product will get paid for?
Let’s talk.
Schedule a discovery call: a one-hour conversation where we get to know your product, your company and your goals, so we can see if and how we can help.